Cover Image
市場調查報告書

全球動物用抗感染藥市場:各動物疾病、技術、動物、地區 - 趨勢及預測

Global Veterinary Anti-infectives market Segmented by Veterinary disease types, by animal types & By Geography - Trends & Forecasts (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 319398
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球動物用抗感染藥市場:各動物疾病、技術、動物、地區 - 趨勢及預測 Global Veterinary Anti-infectives market Segmented by Veterinary disease types, by animal types & By Geography - Trends & Forecasts (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 190 Pages
簡介

全球動物用抗感染藥市場預計2014年達43億7,000萬美元。預期該市場今後也以年複合成長率8.5%擴大,至2019年達到69億2,000萬美元。為了對應動物感染疾病的病例增加,動物用抗感染藥市場踏實成長。

本報告提供全球動物用抗感染藥市場趨勢與未來預測,打入市場的主要企業的競爭環境,市場佔有率,近幾年趨勢與簡介彙整。

第1章 簡介

第2章 市場分析

  • 動物醫療產品市場
  • 動物醫療和人的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物擁有率的上升
    • 營養的改善
    • 消費者對食品安全的認知提高
    • 家畜生產的增加
    • 人畜共通感染疾病、經由食物傳染疾病
  • 阻礙市場的要素
    • 耕種地和水的不足
    • 耕地相關競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 全球動物用抗感染藥市場區隔

  • 全球動物用抗感染藥市場:各疾病
  • 全球動物用抗感染藥市場:各類型
    • 寵物
    • 家畜
  • 全球動物用抗感染藥市場:各地區
    • 北美
    • 歐洲
    • 亞太地區

第5章 競爭環境

  • 市場上主要加入企業
  • 合併、收購
  • 新產品上市
  • 協定、聯合、聯盟

第6章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Description

The global market for veterinary anti-infectives is estimated to be worth USD 4,298 million in 2014. Expected to grow at a healthy CAGR of 6.35%, the market is set to reach USD 6,218 million by 2020. Global veterinary healthcare offers services and products in various segments such as vaccines, parasiticides, anti-infectives, medicinal feed additives, other pharmaceuticals, out of which anti-infectives are growing at a steady pace to combat the increasing number of infectious diseases in animals. It is the second best segment after vaccines and holds about 20% of the global animal healthcare market share.

Global Veterinary Anti-Infectives Market- Market Dynamics

The report studies various driving and restraining factors for the global veterinary anti-infectives market. Some of these are listed below.

Drivers

Increase in pet ownership

Improved nutrition

Increasing zoonotic and foodborne diseases

Restraints

Increased competition for cultivated land and cost-effective production are the major obstacles in the path of global veterinary anti-infectives market.

The report highlights the segment-wise contribution of different anti-incentives by disease, species, and geography. By type of products, the market has been segmented into marbofloxacin, florfenicol, freeze-dried ceftiofur, beta-lactams, oxytetracycline, and aminosidine; by species into companion and farm animals and by geography into North America, Asia-Pacific, Europe and Rest of World.

Some of the key players in the market are:

Bayer Healthcare

Boehringer Ingelheim

Ceva Animal Health, Inc.

Elanco

Merck

Merial (Animal Health Division of Sanofi)

What the Report Offers

Market definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the veterinary anti-infectives market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the veterinary anti-infectives market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. INTRODUCTION

  • 1.1 Market Definition
  • 1.2 Market Recent Trends

2.Market Analysis

  • 2.1 Market Animal Health Products
  • 2.2 Animal medicines vs. human Medicines

3.Market Dynamics

  • 3.1 Market Drivers
    • 3.1.1 Increase in pet ownership
    • 3.1.2 Improved Nutrition
    • 3.1.3 Intensifying consumer focus on food safety
    • 3.1.4 Greater Livestock production
    • 3.1.5 Increasing Zoonotic and Foodborne Diseases
  • 3.2 Market Constraints
    • 3.2.1 Scarcity of arable land and water
    • 3.2.2 Increased competition for cultivated land
    • 3.2.3 Cost effective production
  • 3.3 Porter's Five Force Analysis
    • 3.3.1 Threat of New Entrant
    • 3.3.2 Internal Rivalry
    • 3.3.3 Buyer bargaining power
    • 3.3.4 Supplier bargaining power
    • 3.3.5 Threat of substitutes

4.Global Veterinary Anti-Infective Market Segmentation

  • 4.1 Global Veterinary Anti-infectives Market, By disease
    • 4.1.1 Marbofloxacin
    • 4.1.2 Florfenicol
    • 4.1.3 Freeze-dried ceftiofur
    • 4.1.4 Beta-lactams
    • 4.1.5 Oxytetracycline
    • 4.1.6 Aminosidine
  • 4.2 Global Veterinary Anti-Infectives Market, By species
    • 4.2.1 Companion Animals
      • 4.2.1.1Dogs
      • 4.2.1.2 Cats
      • 4.2.1.2 Horses
    • 4.2.2 Farm animal
      • 4.2.2.1 Cattle
      • 4.2.2.2 Swine
      • 4.2.2.3 Poultry
      • 4.2.2.4 Fish
      • 4.2.2.5 Sheep
  • 4.3 Global Veterinary Anti-Infectives Market Segmentation, By Geography
    • 4.3.1 North America
      • 4.3.1.1 US
      • 4.3.1.2 Mexico
      • 4.3.1.3 Canada
    • 4.3.2 Europe
      • 4.3.2.1 France
      • 4.3.2.2 Italy
      • 4.3.2.3 Germany
      • 4.3.2.4 Spain
      • 4.3.2.5 Sweden
      • 4.3.2.6 Rest of Europe
    • 4.3.3 Asia-Pacific
      • 4.3.3.1 India
      • 4.3.3.2 China
      • 4.3.3.3 Japan
      • 4.3.3.4 Rest of Asia-Pacific
    • 4.3.4 Rest of the World

5. Competitive landscape

  • 5.1 Major players in the market
  • 5.2 mergers and acquisitions
  • 5.3 New product launches
  • 5.4 Agreement, Collaborations, and Partnerships
  • 5.5 Recommendations for New players in the market
  • 5.6 Recommendations for Existing players in the market

6. Company profiles

  • 6.1 Zoetis animal healthcare
    • 6.1.1 Financial Overview
    • 6.1.2 Business overview
    • 6.1.3 Business strategies
  • 6.2 Merck
    • 6.2.1 Financial Overview
    • 6.2.2 Business overview
    • 6.2.3 Business strategies
  • 6.3 Merial (Animal Health Division Of Sanofi)
    • 6.3.1 Financial Overview
    • 6.3.2 Business overview
    • 6.3.3 Business strategies
  • 6.4 Elanco
    • 6.4.1 Financial Overview
    • 6.4.2 Business overview
    • 6.4.3 Business strategies
  • 6.5 Bayer healthcare
    • 6.5.1 Financial Overview
    • 6.5.2 Business overview
  • 6.5 3 Business strategies
  • 6.6 Ceva Animal Health, Inc.
    • 6.6.1 Financial Overview
    • 6.6.2 Business overview
    • 6.6.3 Business strategies
  • 6.7 Virbac
    • 6.7.1 Financial Overview
    • 6.7.2 Business overview
    • 6.7.3 Business strategies
  • 6.8 Boehringer Ingelheim
    • 6.8.1 Financial Overview
    • 6.8.2 Business overview
    • 6.8.3 Business strategies

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top